Country: Brazil

ABIQUIFI Abiquifi (Brazilian Industry Association of Active Pharmaceutical Ingredient) was founded in 1983 to represent and defend the pharmaceutical and API industry. At the beginning of 2010, it also represented companies engaged in the production of pharmaceutical adjuvants, non-active pharmaceutical inputs, and service providers in the sector. The main objective of Abiquifi is to stimulate production, technological development, and exports of active pharmaceutical ingredients manufactured in Brazil. Given the nature of the provider of the drug segment, the entity brings together the various links in this chain, promoting internationalization, research and development actions, and working with the sanitary control and promotion agencies. Brazilian Pharma & Health The Brazilian Pharma & Health Project is an initiative coordinated by the Brazilian Industry Association of Active Pharmaceutical Ingredient (Abiquifi) with the support of the Brazilian Trade and Investment Promotion Agency (ApexBrasil), that aims to expand the participation of companies from Brazilian pharmaceutical and APIs productive chain into the international scenario, seeking to increase exports, technology transfer, investment attraction and the internationalization of the sector. It promotes actions in business intelligence, international marketing, prospective missions, international fairs, business rounds, and trade missions directed to different target markets, including countries from all five continents. | Abiquifi (Brazilian Industry Association of Active Pharmaceutical Ingredient) was founded in 1983 to represent and defend the pharmaceutical and API industry. At the beginning of 2010, it also represented companies engaged in the production of pharmaceutical adjuvants, non-active pharmaceutical inputs, and service providers in the sector. The main objective of Abiquifi is to stimulate production, technological development, and exports of active pharmaceutical ingredients manufactured in Brazil. Given the nature of the provider of the drug segment, the entity brings together the various links in this chain, promoting internationalization, research and development actions, and working with the sanitary control and promotion agencies.